TempraMed is a global leader in innovative, temperature-controlled medication storage and management solutions for people living with chronic conditions. Founded with the mission to safeguard the effectiveness, stability, and safety of life-saving injectable medications, TempraMed develops patented, FDA-registered, space-grade thermal insulation devices that provide fully passive, continuous protection without charging, batteries, or external power.

With a growing portfolio of medical devices and digital health solutions spanning insulin, GLP-1 therapies, biologics, and emergency injectables, and operations across North America, Europe, and Asia, TempraMed enables patients, caregivers, and healthcare providers to confidently manage temperature-sensitive medications, improve adherence, and support better health outcomes—anywhere, anytime.











diabetes management, insulin protection, GLP-1 medications, biologics and biosimilars, epinephrine auto-injectors, chronic disease management, digital health solutions, smart medical devices, connected medical devices, medication adherence, injection tracking, digital logbook, remote patient monitoring